FTC Sues PBMs Over Insulin Prices, Citing a ‘Perverse System’
The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said Friday in announcing an administrative complaint against firms that are divisions of CVS Health,
Biden-Harris FTC Accuses Major Healthcare Companies Of Artificially Inflating Drug Prices In New Lawsuit
The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and their affiliates,
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, Optum and Affiliates
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, Optum and Affiliates
Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of “engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs,
FTC sues three largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged anticompetitive practices that boosted profits while
FTC lawsuit claims drug middlemen are manipulating insulin market
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have engaged in anticompetitive practices that spur price increases, the
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
FTC sues big 3 PBMs for ‘artificially inflated’ insulin prices caused by ‘perverse’ rebating
The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to pay more for insulin.
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.
FTC Release: FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices
Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)--Caremark Rx, Express Scripts (ESI), and OptumRx--and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs,
The FTC has filed a lawsuit over the artificially inflation of the price of insulin
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.
Fierce Healthcare2d
FTC formally sues PBMs over insulin prices and warns manufacturers
“As the complaint explains, the PBMs have created and manage a system in which drug manufacturers compete for formulary ...
FTC Takes Legal Action Against Three Largest PBMs Over High Insulin Prices
Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
The Washington Post on MSN2d
FTC sues pharmacy insurance managers, alleging unfair drug prices
The agency alleges that PBMs, as they are known, benefit financially when the list price of insulin is higher, enabling them to extract heftier rebates from the manufacturers of a product that is ...
East Idaho News1d
New Idaho law to regulate pharmacy benefit managers. Will it reduce prescription drug costs?
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...